Lastly, barriers to, and prospects for, improvements to test methods, and the development of new assays, are considered.
Not only have novel techniques been applied to study drug DNA interactions but such interactions may also be the basis for the development of new assays.
However, the subsequent reporting of severe adverse events in these clinical trials cast doubts on the predictive value of conventional preclinical testing, and encouraged the development of new assays for assessing the relative genotoxicity of various vector designs.
Current efforts are focused on the standardization of HBV DNA assays (qualitative and quantitative), of HBV drug resistance assays as well as in the development of new assays and markers that will help in the prognosis and management of HBV infection (quantitative detection of pre-core mutants and HBV ccc-DNA assays).
Therefore, this work is relevant from the point of view of design and optimization of the biomolecular immobilization cascade on PSi surfaces with the added value of contribution to the development of new assays for detecting ADMA with a view on prevention of cardiovascular diseases.
Development of new assays will require research efforts.
More recently, the development of new assays, in particular the voluntary ethanol consumption and conditioned ethanol preference assays, has demonstrated that flies exhibit addiction-like behavior.
Being genome-wide, it is possible to identify genic regions of high multiplicity, thereby informing the development of new assays for inference.
Public and private funding agencies have responded to these concerns by investing heavily in the development of new assays for microbial surveillance and discovery.
It is readily expandable to additional analytes as the assay reagents (i.e., the capture beads and detection antibodies) are disconnected from the disk architecture and the reader, facilitating rapid development of new assays.
